A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage
Volume 5, Issue 2, April 2024, Pages 85-90
Share article
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
Volume 5, Issue 2, April 2024, Pages 62-68
Share article
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series
Volume 5, Issue 2, April 2024, Pages 74-78
Share article
Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
Volume 5, Issue 2, April 2024, Pages 69-73
Share article
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes
Volume 5, Issue 2, April 2024, Pages 55-61
Share article
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
Volume 5, Issue 2, April 2024, Pages 91-97
Share article
Increased plasma periostin concentration predicts angiographic vasospasm development in non-severe aneurysmal subarachnoid hemorrhage
Volume 5, Issue 1, February 2024, Pages 1-7
Share article
Production and hosting by Elsevier on behalf of KeAi Communications Co. Ltd